ACD/Labs, an informatics company that develops and commercializes solutions in support of chemical and pharmaceutical R&D, will introduce LUMINATA™, an informatics system that enables organizations to establish effective impurity control strategies. This is accomplished through the assembly of analytical, chemical, and process information—all in a single enterprise informatics environment.
Built on ACD/Labs’ multi-technique, vendor-agnostic ACD/Spectrus Platform, Luminata offers data standardization and visualization for comprehensive substance impurity characterization as well as the associated formation and fate of impurities, with chromatographic and spectral data.
Through efficient assembly of data for easy presentation to regulatory bodies, Luminata suits Quality by Design (QbD) approaches in accordance with various industry practices and regulatory requirements. It assists pharmaceutical development organizations in their efforts to characterize and control materials and substances through their lifecycle.
Luminata enhances collaboration between process chemistry, analytical, regulatory, and quality departments. Its capabilities also benefit method development, characterization, long term stability, and forced degradation efforts.